Cargando…
Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study
INTRODUCTION: Use of colistin methanesulfonate (CMS) was abandoned in the 1970s because of excessive nephrotoxicity, but it has been reintroduced as a last-resort treatment for extensively drug-resistant infections caused by gram-negative bacteria (Acinetobacter baumannii, Pseudomonas aeruginosa, Kl...
Autores principales: | Rocco, Monica, Montini, Luca, Alessandri, Elisa, Venditti, Mario, Laderchi, Amalia, De Gennaro, Pascale, Raponi, Giammarco, Vitale, Michela, Pietropaoli, Paolo, Antonelli, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056524/ https://www.ncbi.nlm.nih.gov/pubmed/23945197 http://dx.doi.org/10.1186/cc12853 |
Ejemplares similares
-
The risk factors of colistin methanesulfonate associated nephrotoxicity
por: Tigen, Elif Tükenmez, et al.
Publicado: (2016) -
Dose of colistin: a work in progress?
por: Rocco, Monica, et al.
Publicado: (2015) -
High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia
por: Omrani, Ali S, et al.
Publicado: (2015) -
Susceptibility Testing of Colistin for Acinetobacter baumannii: How Far Are We from the Truth?
por: Sacco, Federica, et al.
Publicado: (2021) -
Population Pharmacokinetics of Colistin Methanesulfonate Sodium and Colistin in Critically Ill Patients: A Systematic Review
por: Zabidi, Mohd Shafie, et al.
Publicado: (2021)